These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30342946)

  • 41. Function of the 90-loop (Thr90-Glu100) region of staphylokinase in plasminogen activation probed through site-directed mutagenesis and loop deletion.
    Rajamohan G; Dahiya M; Mande SC; Dikshit KL
    Biochem J; 2002 Jul; 365(Pt 2):379-89. PubMed ID: 11936951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombolytic agents.
    Collen D; Lijnen HR
    Thromb Haemost; 2005 Apr; 93(4):627-30. PubMed ID: 15841305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. C-terminal lysine residues enhance plasminogen activation by inducing conformational flexibility and stabilization of activator complex of staphylokinase with plasmin.
    Kaur P; Sethi D; Hade MD; Kaur J; Dikshit KL
    Arch Biochem Biophys; 2023 Jul; 743():109671. PubMed ID: 37336343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative effects of staphylokinase and alteplase in rabbit bleeding time models.
    Vanderschueren S; Collen D
    Thromb Haemost; 1996 May; 75(5):816-9. PubMed ID: 8725729
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections.
    Peetermans M; Vanassche T; Liesenborghs L; Claes J; Vande Velde G; Kwiecinksi J; Jin T; De Geest B; Hoylaerts MF; Lijnen RH; Verhamme P
    BMC Microbiol; 2014 Dec; 14():310. PubMed ID: 25515118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thrombolytic efficacy of native recombinant staphylokinase on femoral artery thrombus of rabbits.
    Li CJ; Huang J; Yang ZJ; Cao KJ
    Acta Pharmacol Sin; 2007 Jan; 28(1):58-65. PubMed ID: 17184583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Staphylokinase Enzyme: An Overview of Structure, Function and Engineered Forms.
    Vakili B; Nezafat N; Negahdaripour M; Yari M; Zare B; Ghasemi Y
    Curr Pharm Biotechnol; 2017; 18(13):1026-1037. PubMed ID: 29424308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conjugation with Eight-Arm PEG Markedly Improves the In Vitro Activity and Prolongs the Blood Circulation of Staphylokinase.
    Qi F; Hu C; Yu W; Hu T
    Bioconjug Chem; 2018 Feb; 29(2):451-458. PubMed ID: 29298046
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simultaneous elimination of T- and B-cell epitope by structure-based mutagenesis of single Glu80 residue within recombinant staphylokinase.
    He J; Xu R; Chen X; Jia K; Zhou X; Zhu K
    Acta Biochim Biophys Sin (Shanghai); 2010 Mar; 42(3):209-15. PubMed ID: 20213046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Staphylokinase for a better thrombolytic treatment of heart and platelet diseases].
    Vanderschueren S
    Verh K Acad Geneeskd Belg; 2000; 62(1):69-75. PubMed ID: 10769618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitory effect of staphylokinase on platelet aggregation.
    Suehiro A; Oura Y; Ueda M; Kakishita E
    Thromb Haemost; 1993 Nov; 70(5):834-7. PubMed ID: 7510426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prokaryotic expression, purification and identification of recombinant staphylokinase-HC fusion protein].
    Chen J; Yang K; Guo Z; Zhang YL; Zhang SC; Yang W; Zhao SS; He Q; Wang DQ; Zhou JZ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1208-11. PubMed ID: 23127416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High yielding recombinant Staphylokinase in bacterial expression system--cloning, expression, purification and activity studies.
    Mandi N; Soorapaneni S; Rewanwar S; Kotwal P; Prasad B; Mandal G; Padmanabhan S
    Protein Expr Purif; 2009 Mar; 64(1):69-75. PubMed ID: 19000928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and validation of an indirect competitive ELISA for quantification of recombinant staphylokinase in rabbit plasma: Application to pharmacokinetic study.
    Kumar A; Pulicherla KK; Sambasiva Rao KR
    J Immunoassay Immunochem; 2016; 37(3):228-42. PubMed ID: 26674740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The thermostability of natural variants of bacterial plasminogen-activator staphylokinase.
    Gase A; Birch-Hirschfeld E; Gührs KH; Hartmann M; Vetterman S; Damaschun G; Damaschun H; Gast K; Misselwitz R; Zirwer D
    Eur J Biochem; 1994 Jul; 223(1):303-8. PubMed ID: 8033905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Construction of a novel Staphylokinase (SAK) mutant with low immunogenicity and its evaluation in rhesus monkey.
    Wang M; Chen Y; Fu W; Zou M; Wang Y; Xing W; Wang J; Xu D
    Int J Biol Macromol; 2020 Mar; 146():781-789. PubMed ID: 31730959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS II).
    Armstrong PW; Burton J; Pakola S; Molhoek PG; Betriu A; Tendera M; Bode C; Adgey AA; Bar F; Vahanian A; Van de Werf F;
    Am Heart J; 2003 Sep; 146(3):484-8. PubMed ID: 12947367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural and functional basis of plasminogen activation by staphylokinase.
    Jespers L; Vanwetswinkel S; Lijnen HR; Van Herzeele N; Van Hoef B; Demarsin E; Collen D; De Maeyer M
    Thromb Haemost; 1999 Apr; 81(4):479-85. PubMed ID: 10235424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conjugation of staphylokinase with the arabinogalactan-PEG conjugate: Study on the immunogenicity, in vitro bioactivity and pharmacokinetics.
    Qi F; Qi J; Hu C; Shen L; Yu W; Hu T
    Int J Biol Macromol; 2019 Jun; 131():896-904. PubMed ID: 30914374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Staphylokinase reduces plasmin formation by endogenous plasminogen activators.
    Jin T; Bokarewa M; Zhu Y; Tarkowski A
    Eur J Haematol; 2008 Jul; 81(1):8-17. PubMed ID: 18331597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.